89 related articles for article (PubMed ID: 32696301)
21. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
Fernández-Figueras MT; Puig L; Musulen E; Gilaberte M; Ferrándiz C; Lerma E; Ariza A
Histopathology; 2005 Jun; 46(6):614-21. PubMed ID: 15910592
[TBL] [Abstract][Full Text] [Related]
23. Association of expression of the hedgehog signal with Merkel cell polyomavirus infection and prognosis of Merkel cell carcinoma.
Kuromi T; Matsushita M; Iwasaki T; Nonaka D; Kuwamoto S; Nagata K; Kato M; Akizuki G; Kitamura Y; Hayashi K
Hum Pathol; 2017 Nov; 69():8-14. PubMed ID: 28551328
[TBL] [Abstract][Full Text] [Related]
24. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the potential of the Ki67 index to predict tumor evolution in patients with pituitary adenoma.
Petry C; Poli JHZ; de Azevedo Dossin I; Rech CGSL; Pereira Lima JFS; Ferreira NP; da Costa Oliveira M
Int J Clin Exp Pathol; 2019; 12(1):320-326. PubMed ID: 31933748
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Impact of MCPyV and TIL Subtyping in Merkel Cell Carcinoma: Evidence from a Large European Cohort of 95 Patients.
Ricci C; Righi A; Ambrosi F; Gibertoni D; Maletta F; Uccella S; Sessa F; Asioli S; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Endocr Pathol; 2020 Mar; 31(1):21-32. PubMed ID: 31808008
[TBL] [Abstract][Full Text] [Related]
27. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.
Silva-Figueroa AM; Bassett R; Christakis I; Moreno P; Clarke CN; Busaidy NL; Grubbs EG; Lee JE; Perrier ND; Williams MD
Endocr Pathol; 2019 Dec; 30(4):285-296. PubMed ID: 31734935
[TBL] [Abstract][Full Text] [Related]
28. PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters.
Ricci C; Morandi L; Righi A; Gibertoni D; Maletta F; Ambrosi F; Agostinelli C; Uccella S; Asioli S; Sessa F; Pellilli M; Maragliano R; La Rosa S; Papotti MG; Asioli S
Mod Pathol; 2019 Sep; 32(9):1359-1372. PubMed ID: 30976104
[TBL] [Abstract][Full Text] [Related]
29. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors.
Alshaikh OM; Asa SL; Mete O; Ezzat S
Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322
[TBL] [Abstract][Full Text] [Related]
30. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
[TBL] [Abstract][Full Text] [Related]
31. Retrospective study on the correlation between 18-fluorodeoxyglucose uptake in positron emission tomography-computer tomography and tumour volume, cytological activity as assessed with Ki-67 and GLUT-1 staining in 10 cases of Merkel cell carcinoma.
Kitamura S; Yanagi T; Inamura-Takashima Y; Imafuku K; Hata H; Uehara J; Ishida Y; Otsuka A; Hirata K; Shimizu H
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e285-e287. PubMed ID: 29377285
[No Abstract] [Full Text] [Related]
32. Somatostatin receptor type 2 expression in Merkel cell carcinoma as a prognostic factor.
Orlova KV; Delektorskaya VV; Vishnevskaya YV; Kondratieva TT; Orel NF; Markovich AA; Demidov LV; Subramanian S
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e236-e237. PubMed ID: 29265481
[No Abstract] [Full Text] [Related]
33. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G; La Rosa S
Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
[TBL] [Abstract][Full Text] [Related]
34. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
[TBL] [Abstract][Full Text] [Related]
35. Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.
Amaral T; Leiter U; Garbe C
Rev Endocr Metab Disord; 2017 Dec; 18(4):517-532. PubMed ID: 28916903
[TBL] [Abstract][Full Text] [Related]
36. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection.
Moshiri AS; Doumani R; Yelistratova L; Blom A; Lachance K; Shinohara MM; Delaney M; Chang O; McArdle S; Thomas H; Asgari MM; Huang ML; Schwartz SM; Nghiem P
J Invest Dermatol; 2017 Apr; 137(4):819-827. PubMed ID: 27815175
[TBL] [Abstract][Full Text] [Related]
37. The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.
Milione M; Maisonneuve P; Spada F; Pellegrinelli A; Spaggiari P; Albarello L; Pisa E; Barberis M; Vanoli A; Buzzoni R; Pusceddu S; Concas L; Sessa F; Solcia E; Capella C; Fazio N; La Rosa S
Neuroendocrinology; 2017; 104(1):85-93. PubMed ID: 26943788
[TBL] [Abstract][Full Text] [Related]
38. Dramatic Increase in the Incidence and Mortality from Merkel Cell Carcinoma in the United States.
Fitzgerald TL; Dennis S; Kachare SD; Vohra NA; Wong JH; Zervos EE
Am Surg; 2015 Aug; 81(8):802-6. PubMed ID: 26215243
[TBL] [Abstract][Full Text] [Related]
39. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
